The mV2G atlas provides searchable variant- and gene-centered interfaces, an interactive browser for visualizing variants, target genes, cis-regulatory elements, and chromatin states, as well as downloadable datasets, and a unified tissue-specific V2G prioritization framework.
Abstract
The multiomic Variant-to-Gene (mV2G, https://mv2g.hbliulab.org) is a comprehensive atlas that integrates diverse functional genomic evidence to prioritize tissue-specific variant-to-gene (V2G) associations. While genome-wide association studies (GWAS) have identified millions of associations between genetic variants and diseases, translating these findings into biological mechanisms remains challenging because >90% of variants reside in noncoding regions. Existing V2G resources provide complementary regulatory evidence but are fragmented and often lack tissue-specific interpretation. To address this challenge, we constructed the mV2G atlas by integrating 24 types of functional genomic evidence across 50 human tissues, including molecular quantitative trait loci, enhancer–gene predictions, three-dimensional chromatin interactions, and experimental validation. The atlas contains 188,634,118 evidence-supported V2G pairs involving 13,618,039 variants and 69,521 genes. We further developed a unified tissue-specific V2G prioritization framework and prioritized 1,530,420 high-confidence functional V2G pairs involving 1,131,316 unique variants, with 87% exhibiting tissue-specificity. The mV2G atlas provides searchable variant- and gene-centered interfaces, an interactive browser for visualizing variants, target genes, cis-regulatory elements, and chromatin states, as well as downloadable datasets. By integrating complementary regulatory evidence into a unified framework, mV2G provides an accessible resource for interpreting the functional and phenotypic impact of genomic variation in relevant tissues for human diseases. GRAPHICAL ABSTRACT
Structural variants (SVs), including variable number tandem repeats (VNTRs), are a major source of human genetic variation, but their impact on the proteome remains poorly characterized. Using a long-read assembly-based reference panel, we imputed 54,578 general SVs and 15,826 VNTRs in 54,306 UK Biobank participants to...
P. Yuan, W. Bai, J. Hou et al.· medRxiv· 0 citations
Glioblastoma (GBM) remains a highly aggressive malignancy, and the contribution of ferroptosis-related genes to disease susceptibility remains incompletely understood. A genetically anchored, multistage framework was applied to prioritize ferroptosis-related genes associated with GBM. Among 483 genes curated from FerrD...
Zhi-Rui Liao, Ming-Ming Xian, Fan-Meng Zeng et al.· Journal of Visualized Experi...· 0 citations
An approach comprising locus-specific stratification (LSS) and gene regulatory prioritisation score (GRPS), which uniquely considers multi-signals during fine-mapping and target gene identification, to address issues arising from multi-signals in complex diseases.
Jing Zhang, Qiao-Qiao Liu, Ye Zhu et al.· Nature Communications· 0 citations
A personalized functional genomics atlas for Alzheimer’s disease that uses knowledge-guided graph neural networks to analyze donor-level functional genomics, identify disease subpopulations and trajectories, and link genetic variants to gene regulation is summarized.
P. Chandrashekar, S. Alatkar, Noah Cohen Kalafut et al.· Nature Communications· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.